doi:10.3969/j.issn.1004-583X.2025.02.014

Abstract

CLC Number:

R541.1

Add to citation manager EndNote|Ris|BibTeX

URL: http://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2025.02.014

http://www.lchc.cn/EN/Y2025/V40/I2/172

Figures/Tables 1

References 89

[1]	Homma S, Messé SR, Rundek T, et al. Patent foramen ovale[J]. Nat Rev Dis Primers, 2016, 2:15086. doi: 10.1038/nrdp.2015.86 pmid: 27188965
[2]	Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramenovale versus medical therapy after cryptogenic stroke[J]. N Eng JMed, 2013, 368(12):1092-1100.
[3]	Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale:The PFO-ASA study. Atrial Septeal Aneurysm[J]. Stroke, 2002, 33:706-712. pmid: 11872892
[4]	Blankenship JC. PFO closure: Where are the neurologists?[J]. Catheter Cardiovasc Interv, 2018, 92(1):187-188.
[5]	Mojadidi MK, Zaman MO, Elgendy IY, et al. Cryptogenic stroke and patent foramen ovale[J]. Am Coll Cardiol, 2018, 6, 71(9):1035-1043.
[6]	Hayashida K, Fukuchi K, Inubushi M, et al. Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after valsalva radionuclide venography[J]. Nucl Med, 2001, 42(6):859-863.
[7]	Hansen M, Charies A. Diferences in reatment response between mioraine with aura and migraine without aura:Essons rom cinical practice and RCTs[J], Headache Pain, 2019, 20(1):96.
[8]	Demir B, Caglar IM, Ungan I, et al. Mean platelet volume is elevated in patients with patent foramen ovale[J]. Arch Med Sci, 2013, 9(6):1055-1061. doi: 10.5114/aoms.2013.38687 pmid: 24482650
[9]	Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale[J]. Ann Neurol, 2010, 67(2):221-229. doi: 10.1002/ana.21871 pmid: 20225282
[10]	Sánchez-Porras R, Robles-Cabrera A, Santos E. Despolarización cortical extendida: Un nuevo mecanismo fisiopatológico en las enfermedades neurológicas [Cortical spreading depolarization: A new pathophysiological mechanism in neurological diseases][J]. Med Clin (Barc), 2014, 142(10):457-462. doi: 10.1016/j.medcli.2013.05.029 pmid: 23928069
[11]	Vitale M, Tottene A, Zarin Zadeh M, et al. Mechanisms of initiation of cortical spreading depression[J]. Headache Pain, 2023, 24(1):105.
[12]	Corno S, Giani L, Laganà MM, et al. The brain effect of the migraine attack: An ASL MRI study of the cerebral perfusion during a migraine attack[J]. Neurol Sci, 2018, 39(1):73-74.
[13]	Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9[J]. Clin Invest, 2004, 113(10):1447-1455.
[14]	Wang W, Redecker C, Bidmon H, et al. De-aved neuronal death and damace of GDNF family recepiors in CA1folowing foca cere-bral ischemialul[J]. Brain Res, 2004, 1023(1):92-101. pmid: 15364023
[15]	Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization[J]. Physiol Rev, 2001, 81(3):1065-1096. doi: 10.1152/physrev.2001.81.3.1065 pmid: 11427692
[16]	Vinogradova LV, Suleymanova EM, Medvedeva TM. Transient loss of interhemispheric functional connectivity following unilateral cortical spreading depression in awake rats[J]. Cephalalgia, 2021, 41(3):353-365. doi: 10.1177/0333102420970172 pmid: 33164563
[17]	Vigna C, Marchese N, Inchingolo V, et al. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesons:A case-control study[J]. JACC Cardiovasc lnterv, 2009, 2(2):107-113.
[18]	Saengjaroentham C, Supornsilpchai W, Ji-Au W, et al. Serotonin depetion can enhance the cerebrovascular responses induced by cortical spreading deoression via the nitric oxide pathway[J]. Int J Neurosci, 2015, 125(2):130-139. doi: 10.3109/00207454.2014.908876 pmid: 24670256
[19]	Beda RD, Gill EA Jr. Patent foramen ovale: Does it play a role in the pathophysiology of migraine headache?[J]. Cardiol Clin, 2005, 23(1):91-96. pmid: 15676272
[20]	Sun L, Chu T, Wang Y, et al. Radiolabeling and biodistribution of a nasopharyngeal carcinoma-targeting peptide identified byin vivophage display[J]. Acta Biochim Biophys Sin(Shanghai), 2007, 39(8):624-632.
[21]	Sacco S, Pistoia F, Degan D, et al. Conventional vascular risk factors:Their role in the association between migraine and cardiovascular diseases[J]. Cephalalgia, 2015, 35(2):146-164.
[22]	Mordecai YT, Wester GP, Busto R. Ischemia induced extracellular release of serotonin plays a Rolein CAl neuronal cell death in Rats[J]. Stroke, 1992, 23:1595.
[23]	Du B, Yu J, Zhou ZL, et al. Selection of the peptides specifically binding to hepatoma by using phage display in vivo[J]. Zhong Hua Zhong Liu Za Zhi, 2005, 27(11):645-647.
[24]	Guo ZN, Xing Y, Liu J, et al. Compromised dynamic cerebral autoregulation in patients with a right-to-left shunt: A potential mechanism of migraine and cryptogenic stroke[J]. PLoS One, 2014, 9(8):e1048-1049.
[25]	Singh HS, Katchi F, Naidu SS. PFO Closure for cryptogenic stroke: A review and clinical treatment algorithm[J]. Cardiol Rev, 2017, 25(4):147-157. doi: 10.1097/CRD.0000000000000148 pmid: 28574934
[26]	Gillow SJ, Lee VH. PFO closure for cryptogenic stroke[J]. Curr Atheroscler Rep, 2015, 17(8):45. doi: 10.1007/s11883-015-0525-6 pmid: 26076907
[27]	Ben-Assa E, Rengifo-Moreno P, Al-Bawardy R, et al. Effect of residual interatrial shunt on migraine burden after transcatheter closure of patent foramen ovale[J]. JACC Cardiovasc Interv, 2020, 13(3):293-302.
[28]	De Vecchis R, Baldi C, Cantatrione S. Transcatheter closure of PFO as secondary prevention of cryptogenic stroke[J]. Herz, 2017, 42(1):45-50. doi: 10.1007/s00059-016-4432-6 pmid: 27255114
[29]	Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial[J]. Eur Heart J, 2016, 37(26):2029-2036. doi: 10.1093/eurheartj/ehw027 pmid: 26908949
[30]	Shi YJ, Lv J, Han XT, et al. Migraine and percutaneous patent foramen ovale closure: A systematic review and meta-analysis[J]. BMC Cardiovasc Disord, 2017, 17(1):203.
[31]	Miranda B, Fonseca AC, Ferro JM. Patent foramen ovale and stroke[J]. Neurol, 2018, 265(8):1943-1949.
[32]	Radico F, Foglietta M, Di Fulvio M, et al. The 'dreaded PFO': Anatomical and functional features of high risk for stroke[J]. Eur Heart J Suppl, 2021, 23(Suppl E):E189-E193.
[33]	Overell JR, Lees KR, Bone I. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism[J]. Circulation, 2001, 103(10):E56. doi: 10.1161/01.cir.103.10.e56 pmid: 11245659
[34]	Khan AR, Bin Abdulhak AA, Sheikh MA, et al. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: A systematic review and meta-analysis[J]. Am Coll Cardiol Intv, 2013, 6:1316-1323.
[35]	Cheng T, Gonzalez JB, Testai FD. Advances and ongoing controversies in PFO closure and cryptogenic stroke[J]. Handb Clin Neurol, 2021, 177:43-56. doi: 10.1016/B978-0-12-819814-8.00009-3 pmid: 33632456
[36]	Ekker MS, Verhoeven JI, Vaartjes I, et al. Stroke incidence in young adults according to age, subtype, sex, and time trends[J]. Neurology, 2019, 92(21):e2444-e2454.
[37]	Leppert MH, Ho PM, Burke J, et al. Young women had more strokes than young men in a large, united states claims sample[J]. Stroke, 2020, 51(11):3352-3355.
[38]	Kent DM, Saver JL, Kasner SE, et al. Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke[J]. JAMA, 2021, 326(22):2277-2286. doi: 10.1001/jama.2021.20956 pmid: 34905030
[39]	Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association/American Stroke Association[J]. Stroke, 2021, 52(7):e364-e467.
[40]	Mas JL, Derumeaux G, Guillon B, et al. CLOSE investigators: Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke[J]. N Engl J Med, 2017, 377(11): 1011-1021.
[41]	Arngrim N, Hougaard A, Schytz HW, et al. Effect of hypoxia on BOLD fMRI response and total cerebral blood flow in migraine with aura patients[J]. Cereb Blood Flow Metab, 2019, 39(4):680-689.
[42]	Kumar P, Kijima Y, West BH, et al. Between patent foramen ovale and migraine[J]. Neuroimaging Clin N Am, 2019, 29(2):261-270.
[43]	Kijima Y, Miller N, Noureddin N, et al. The degree of right-to-left shunt is associated with visual auradue to migraine[J]. Am Coll Cardiol, 2015, 66(15):738.
[44]	Rayhill M, Burch R. PFO and migraine: Is there a role for closure?[J]. Curr Neurol Neurosci Rep, 2017, 17(3):20.
[45]	Trabattoni D, Brambilla M, Canzano P, et al. Migraine in patients undergoing PFO closure: Characterization of a platelet-associated pathophysiological mechanism: The LEARNER study[J]. JACC Basic Transl Sci, 2022, 7(6):525-540. doi: 10.1016/j.jacbts.2022.02.002 pmid: 35818509
[46]	Caputi L, Usai S, Carriero MR, et al. Microembolic air load during contrast-transcranial Doppler: A trigger for migraine with aura?[J]. Headache, 2010, 50:1320-1327. doi: 10.1111/j.1526-4610.2010.01621.x pmid: 20132338
[47]	Wilmshurst PT, Pearson MJ, Nightingale S, et al. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura[J]. Heart, 2004, 90:1315-1320. doi: 10.1136/hrt.2003.025700 pmid: 15486131
[48]	Snijder RJ, Luermans JG, de Heij AH, et al. Patent foramen ovale with atrial septal aneurysm is strongly associated with migraine with aura: A large observational study[J]. Am Heart Assoc, 2016, 5:3771.
[49]	West BH, Noureddin N, Mamzhi Y, et al. Frequency of patent foramen ovale and migrainein patients with cryptogenic stroke[J]. Stroke, 2018, 49(5):1123-1128.
[50]	Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions[J]. JAMA, 2004, 291(4):427-434. doi: 10.1001/jama.291.4.427 pmid: 14747499
[51]	Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts[J]. Mayo Clin. Proc, 1984, 59:17-20. doi: 10.1016/s0025-6196(12)60336-x pmid: 6694427
[52]	Kerut EK, Norfleet WT, Plotnick GD, et al. Patent foramen ovale: A review of associated conditions and the impact of physiological size[J]. J Am Coll Cardiol, 2001, 38: 613-623. doi: 10.1016/s0735-1097(01)01427-9 pmid: 11527606
[53]	Cabrera JÁ, Urmeneta Ulloa J, Jímenez de la Peña M, et al. White-matter lesions and cortical cerebral blood flow evaluation by 3D arterial spin-labeled perfusion MRI in asymptomatic divers: Correlation with patent foramen ovale ocurrence[J]. J Clin Med, 2023, 12(8):2866.
[54]	Schwerzmann M, Seiler C, Lipp E, et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers[J]. Ann Intern Med, 2001, 134(1):21-24. doi: 10.7326/0003-4819-134-1-200101020-00009 pmid: 11187416
[55]	Reul J, Jung A, Thron A, et al. Central nervous system lesions and cervical disc herniations in amateur divers[J]. Lancet, 1995, 345:1403-1405. pmid: 7760611
[56]	Balestra C, Germonpré P. Correlation between patent foramen ovale, cerebral “lesions” and neuropsychometric testing in experienced sports divers: Does diving damage the brain?[J]. Front Psychol, 2016, 7:696.
[57]	Tsushima Y, Endo K. MR imaging in the evaluation of chronic or recurrent headache[J]. Radiology, 2005, 235:575-579. pmid: 15858096
[58]	Swartz RH, Kern RZ. Migraine is associated with mag netic resonance imaging white matter abnormalities: A meta analysis[J]. Arch Neurol, 2004, 61(9):1366-1368.
[59]	Kruit M, Buchem MV, Launer L, et al. Migraine isassociated with an increased risk of deep white mat-ter lesions, subclinical posterior circulation infarctsand brain iron accumulation: The population-based MRI CAMERA study[J]. Cephalalgia, 2010, 30(2):129-136. doi: 10.1111/j.1468-2982.2009.01904.x pmid: 19515125
[60]	Rocca MA, Ceccarelli A, Falini A, et al. Brain gray matter changes in migraine patients with T2-visible lesions: A 3-T MRI study[J]. Stroke, 2006, 37(7):1765-1770. doi: 10.1161/01.STR.0000226589.00599.4d pmid: 16728687
[61]	May A, Gasser C. Magnetic resonance-based morphome try: A window into structural plasticity of the brain[J]. Curr Opin Neurol, 2006, 19(4):407-411.
[62]	Messina R, Gollion C, Christensen RH, et al. Functional MRI in migraine[J]. Curr Opin Neurol, 2022, 35(3):328-335. doi: 10.1097/WCO.0000000000001060 pmid: 35674076
[63]	Genois É, Gagnon L, Desjardins M. Modeling of vascular space occupancy and BOLD functional MRI from first principles using real microvascular angiograms[J]. Magn Reson Med, 2021, 85(1):456-468.
[64]	Hall CN, Reynell C, Gesslein B, et al. Capillary pericytes regulate cerebral blood flow in health and disease[J]. Nature, 2014, 508(7494):55-60.
[65]	Lasek-Bal A, Kidoń J, Błaszczyszyn M, et al. BOLD fMRI signal in stroke patients and its importance for prognosis in the subacute disease period-preliminary report[J]. Neurol Neurochir Pol, 2018, 52(3):341-346. doi: S0028-3843(17)30322-5 pmid: 29329693
[66]	Kroll H, Zaharchuk G, Christen T, et al. Resting-state BOLD MRI for perfusion and ischemia[J]. Top Magn Reson Imaging, 2017, 26(2):91-96. doi: 10.1097/RMR.0000000000000119 pmid: 28277456
[67]	Lake EM, Bazzigaluppi P, Stefanovic B. Functional magnetic resonance imaging in chronic ischaemic stroke[J]. Philos Trans R Soc Lond B Biol Sci, 2016, 371(1705):20150353.
[68]	Chollet F, DiPiero V, Wise RJS, et al. The functional anatomy of motor recovery after stroke in humans: A study with positron emission tomography[J]. Ann Neurol, 1991, 29:63-71. pmid: 1996881
[69]	Weiller C, Ramsay SC, Wise RJS, et al. Individual patterns of functional reorganisation in the human cerebral cortex after capsular infarction[J]. Ann Neurol, 1993, 33(2):181-189. pmid: 8434880
[70]	Feydy A, Cardlier R, Roby-Brami A, et al. Longitudinal study of motor recovery after stroke, recruitment and focusing of brain activation[J]. Stroke, 2002, 33(6):1610-1617. doi: 10.1161/01.str.0000017100.68294.52 pmid: 12053000
[71]	Netz J, Lammers T, Homberg V. Reorganization of motor output in the non-affected hemisphere after stroke[J]. Brain, 1997, 120(Pt 9):1579-1586.
[72]	Carter AR, Astafiev SV, Lang CE, et al. Resting inter-hemispheric fMRI connectivity predicts performance after stroke[J]. Ann Neurol, 2010, 67:365-375. doi: 10.1002/ana.21905 pmid: 20373348
[73]	Chong CD, Schwedt TJ, Hougaard A. Brain functional connectivity in headache disorders: A narrative review of MRI investigations[J]. J Cereb Blood Flow Metab, 2019, 39(4):650-669.
[74]	Cao Y, Welch KM, Aurora S, et al. Functional MRI-BOLD of visually triggered headache in patients with migraine[J]. Arch Neurol, 1999, 56(5):548-554.
[75]	James MF, Smith MI, Bockhorst KH, et al. Cortical spreading depression in the gyrencephalic feline brain studied by magnetic resonance imaging[J]. J Physiol, 1999, 519(Pt 2):415-425.
[76]	Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex[J]. Proc Natl Acad Sci U S A, 2001, 98(8):4687-4692.
[77]	Hougaard A. Investigations of functional and structural changes in migraine with aura by magnetic resonance imaging[J]. Dan Med J, 2015, 62(8):B5129.
[78]	Bramanti P, Grugno R, Vitetta A, et al. Ictal and interictal hypoactivation of the occipital cortex in migraine with aura. A neuroimaging and electrophysiological study[J]. Funct Neurol, 2005, 20(4):169-171. pmid: 16483455
[79]	de Tommaso M, Trotta G, Vecchio E, et al. Brain networking analysis in migraine with and without aura[J]. J Headache Pain, 2017, 18(1):98. doi: 10.1186/s10194-017-0803-5 pmid: 28963615
[80]	Kreczmański P, Wolak T, Lewandowska M, et al. Altered functional brain imaging in migraine patients: BOLD preliminary study in migraine with and without aura[J]. Neurol Neurochir Pol, 2019, 53(4):304-310. doi: 10.5603/PJNNS.a2019.0035 pmid: 31441496
[81]	Yu HX, Li HY, Yin ZX, et al. The fMRI research of vestibular migraine neural pathways[J]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2017, 31(12):906-909.
[82]	Arngrim N, Hougaard A, Ahmadi K, et al. Heterogenous migraine aura symptoms correlate with visual cortex functional magnetic resonance imaging responses[J]. Ann Neurol, 2017, 82(6):925-939. doi: 10.1002/ana.25096 pmid: 29130510
[83]	Hernandez-Garcia L, Lahiri A, Schollenberger J. Recent progress in ASL[J]. Neuroimage, 2019, 187:3-16. doi: S1053-8119(17)31119-9 pmid: 29305164
[84]	Chalela JA, Alsop DC, Gonzalez-Atavales JB, et al. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling[J]. Stroke, 2000, 31(3):680-687. doi: 10.1161/01.str.31.3.680 pmid: 10700504
[85]	Kidoguchi M, Akazawa A, Komori O, et al. Prediction of occurrence of cerebral infarction after successful mechanical thrombectomy for ischemic stroke in the anterior circulation by arterial spin labeling[J]. Clin Neuroradiol, 2023, 33(4):965-971. doi: 10.1007/s00062-023-01295-x pmid: 37280389
[86]	Yu W, Yang J, Liu L, et al. The value of diffusion weighted imaging in predicting the clinical progression of perforator atery cerebral infarction[J]. Neuroimage Clin, 2022, 35:103-117.
[87]	Gollion C. Cortical excitability in migraine: Contributions of magnetic resonance imaging[J]. Rev Neurol (Paris), 2021, 177(7):809-815.
[88]	Faragó P, Tóth E, Kocsis K, et al. Altered resting state functional activity and microstructure of the white matter in migraine with aura[J]. Front Neurol, 2019, 10:1039. doi: 10.3389/fneur.2019.01039 pmid: 31632336
[89]	Porcaro C, Di Renzo A, Tinelli E, et al. A hypothalamic mechanism regulates the duration of a migraine attack: Insights from microstructural and temporal complexity of cortical functional networks analysis[J]. Int J Mol Sci, 2022, 23(21):13238.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 89

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Duo, Li Yanling, Guo Zhaoxia, Li Jianfeng, Zhang Huijuan, Xie Ping. Anomalous left coronary artery from the pulmonary artery: A case report and literature review [J]. Clinical Focus, 2023, 38(7): 618-622.
[2]	Zhang Xueqian, Li Yang, Xu Guodong, Lyu Peiyuan. Analysis of demographic, clinical and imaging in patients with acute cerebral infarction caused by patent foramen ovale [J]. Clinical Focus, 2023, 38(6): 500-503.
[3]	Ren Ling, Jiang Shan. Relationship between serum amyloid A, high sensitive C-reactive protein, nitric oxide and adverse cardiovascular events in patients with stable coronary heart disease [J]. Clinical Focus, 2021, 36(1): 16-20.
[4]	Chen Junhui, Su Peng, Liu Shurao, Gao Xia,Song Pan, Yang Jianping. Effect of angiotensin converting enzyme inhibitor or angiotensin Ⅱ receptor blocker on right ventricular structure and function in transposition of great arteries with intra-atrial baffle: a meta-analysis [J]. Clinical Focus, 2016, 31(3): 307-314.
[5]	. [J]. Clinical Focus, 2015, 30(9): 1061-1062.
[6]	. Study on atrioventricular junction structural anomalies in patients with transposition of great arteries using 256-slice spiral CT [J]. Clinical Focus, 2015, 30(7): 769-772.
[7]	Zhang Gejun;Xu Zhongying;Jiang Shiliang;Zhao Shihua;Ling Jian;Song Huijun;Wan Junyi. Efficiency evaluation of retrograde transcatheter closure of ventricular septal defects using amplatzer duct occluder Ⅱ [J]. Clinical Focus, 2015, 30(6): 601-604.
[8]	ZHANG Ge-jun;LING Jian;JIANG Shi-liang;XU Zhong-ying;ZHAO Shi-hua;ZHENG Hong;SONG Hui-jun;JIN Jing-lin. Transcatheter intervention of residual pulmonary stenosis after surgical correction of Tetralogy of Fallot and efficiency evaluation [J]. Clinical Focus, 2014, 29(6): 634-636.
[9]	YIN Ren-lin;JIANG Ting-bo;XUE Feng;HE Zhi-song. Correlation between mean platelet volume and coronary collateral circulation formation in patients with acute coronary syndrome [J]. CLINICAL FOCUS, 2014, 29(2): 138-140.
[10]	TIAN Xiao-yu;CHEN Hui-fen;YANG Shi-bin;TIAN Chang-hai;WANG Xiao-ning;ZHANG Hui-feng. Impact factors on plasma levels of B-type natriuretic peptide in children with congenital heart disease in perioperative period [J]. CLINICAL FOCUS, 2013, 28(10): 1107-1.10911e+007.
[11]	. [J]. Clinical Focus, 2013, 28(1): 110-112.
[12]	. [J]. Clinical Focus, 2012, 27(21): 1889-1891.
[13]	. [J]. Clinical Focus, 2012, 27(20): 1812-1813.
[14]	. [J]. Clinical Focus, 2012, 27(16): 1431-1432.
[15]	. [J]. Clinical Focus, 2012, 27(13): 1145-1146.